Author Response: Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease

Affiliations

Comment

Thomas H Massey et al. Neurology. 2022.

. 2022 Mar 22;98(12):515.

doi: 10.1212/WNL.0000000000200162.

No abstract available

Comment on

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
McAllister B, Gusella JF, Landwehrmeyer GB, Lee JM, MacDonald ME, Orth M, Rosser AE, Williams NM, Holmans P, Jones L, Massey TH; REGISTRY Investigators of the European Huntington's Disease Network. McAllister B, et al. Neurology. 2021 May 11;96(19):e2395-e2406. doi: 10.1212/WNL.0000000000011893. Epub 2021 Mar 25. Neurology. 2021. PMID: 33766994 Free PMC article. Clinical Trial.
Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
Kropshofer H, Häring DA, Kappos L, Leppert D, Kuhle J. Kropshofer H, et al. Neurology. 2022 Mar 15;98(11):470-471. doi: 10.1212/WNL.0000000000200132. Neurology. 2022. PMID: 35288475 No abstract available.